APA (7th ed.) Citation

Ogilvie, R. P., Layton, J. B., Lloyd, P. C., Jiao, Y., Djibo, D. A., Wong, H. L., . . . Shoaibi, A. (2024). Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States. BMC Pediatrics, 24(1), . https://doi.org/10.1186/s12887-024-04756-5

Chicago Style (17th ed.) Citation

Ogilvie, Rachel P., et al. "Effectiveness of BNT162b2 COVID-19 Primary Series Vaccination in Children Aged 5–17 Years in the United States." BMC Pediatrics 24, no. 1 (2024). https://doi.org/10.1186/s12887-024-04756-5.

MLA (9th ed.) Citation

Ogilvie, Rachel P., et al. "Effectiveness of BNT162b2 COVID-19 Primary Series Vaccination in Children Aged 5–17 Years in the United States." BMC Pediatrics, vol. 24, no. 1, 2024, https://doi.org/10.1186/s12887-024-04756-5.